Safety and TDM of Continuous Infusion Vancomycin Through Continuous Renal Replacement Therapy Solution
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this investigation is to evaluate the safety of delivering continuous infusion
(CI) vancomycin in pediatric CRRT by utilizing CI via by mixing the vancomycin into the CRRT
solution(s). The secondary objectives are to describe the ability to achieve therapeutic
vancomycin concentrations by utilizing this new delivery technique.
Primary Objectives:
To determine whether delivering continuous infusion vancomycin mixed into the CRRT solution
can maintain therapeutic levels of drug in patients being treated for proven or suspected
Gram-positive bacterial infections.